Sign in

CIK 0001080014

  • Large accelerated filer

Innoviva, Inc.

Sign in to watch
Ticker
INVA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943265960
Phone
+1 650-238-9600
Business address
1350 OLD BAYSHORE HIGHWAY, SUITE 400, BURLINGAME, CA, 94010
Former names
THERAVANCE INC, ADVANCED MEDICINE INC
  1. 4 Derivatives Options or other derivatives
  2. 3 Insider Initial Statement of Ownership
  3. 4 Shares withheld for taxes Chief Accounting Officer gave up 828 shares (to pay taxes)
  4. 3 Insider Initial Statement of Ownership
  5. 4 Shares withheld for taxes Chief Accounting Officer gave up 830 shares (to pay taxes)
  6. 4 Insider Changes in Ownership
  7. 4 Shares withheld for taxes Chief Accounting Officer gave up 828 shares (to pay taxes)
  8. 4 Derivatives Options or other derivatives
  9. 4 Grant or award Director acquired 12,647 shares (grant or award)
  10. 4 Grant or award Director acquired 12,647 shares (grant or award)
  11. 4 Grant or award Director acquired 12,647 shares (grant or award)
  12. 4 Grant or award Director acquired 12,647 shares (grant or award)
  13. 4 Grant or award Director acquired 12,647 shares (grant or award)
  14. 4 Grant or award Director acquired 12,647 shares (grant or award)
  15. 4 Open-market buy Director bought 5,385,208 shares at $5.00 ($26,926,040)
  16. 4 Grant or award Chief Accounting Officer acquired 6,691 shares (grant or award)
  17. 4 Insider Changes in Ownership
  18. 4 Shares withheld for taxes Chief Accounting Officer gave up 2,277 shares (to pay taxes)
  19. 4 Open-market buy Director bought 3,614,792 shares at $5.00 ($18,073,960)
  20. 4 Shares withheld for taxes Chief Accounting Officer gave up 758 shares (to pay taxes)

Page 5 of 39 · 776 filings